Floatz logo

Therapeutic Asset Ratings

5,099 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pelabresib
Cancer
Novartis PharmaceuticalsP3B (61)
Pembrolizumab
Cervical Cancer
Merck Sharp & Dohme LLCP3B (61)
Pembrolizumab
Nonpapillary Renal Cell Carcinoma
City of Hope Medical CenterP3B (61)
Pembrolizumab
Ovarian Carcinoma
Roswell Park Cancer InstituteP3B (61)
Pembrolizumab
Esophageal Cancer
Essen BiotechP3B (61)
Pembrolizumab
Esophageal Squamous Cell Carcinoma
GV20 TherapeuticsP3B (61)
Pembrolizumab
Fallopian Tube Cancer
OncoC4, Inc.P3B (61)
Pembrolizumab
Hodgkins Lymphoma
Michael Spinner, MDP3B (61)
Pembrolizumab
Lung Cancer
City of Hope Medical CenterP3B (61)
Pembrolizumab
Metastatic Melanoma
Brown UniversityP3B (61)
Pembrolizumab
Metastatic Neoplasm
Mohammed MilhemP3B (61)
Pembrolizumab
Ovarian Neoplasm
GlaxoSmithKlineP3B (61)
Pembrolizumab
Small Cell Lung Carcinoma
GV20 TherapeuticsP3B (61)
Pitolisant
Prader-Willi Syndrome
Harmony Biosciences Management, Inc.P3B (61)
Plerixafor
Plasma Cell Myeloma
Thomas Jefferson UniversityP3B (61)
Plinabulin
Non-Small Cell Lung Carcinoma
BeyondSpring Pharmaceuticals Inc.P3B (61)
Polatuzumab Vedotin
Large B-Cell Lymphoma
Ruijin HospitalP3B (61)
Ppsv23
Relapsing-Remitting Multiple Sclerosis
CelgeneP3B (61)
Pralatrexate
Nodal T-Follicular Helper Cell Lymphoma, Follicular Type
Corvus Pharmaceuticals, Inc.P3B (61)
Prednisolone
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P3B (61)
Prednisolone
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3B (61)
Prednisolone
Primary Mediastinal Large B-Cell Lymphoma
National Research Center for Hematology, RussiaP3B (61)
Prednisolone
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3B (61)
Prednisone
Breast Cancer
M.D. Anderson Cancer CenterP3B (61)
Prednisone
Metastatic Malignant Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP3B (61)
Showing 2151 to 2175 of 5,099 assets
PreviousPage 87 of 204Next